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Translation of mRNA encoding the L1 and L2 capsid proteins of papillomavirus (PV) is restricted in vivo
to differentiated epithelial cells, although transcription of the L1 and L2 late genes occurs more widely. The
codon composition of PV late genes is quite different from that of most mammalian genes. To test the possibility
that PV late gene codon composition determines the efficiency of PV late gene expression in some cell types,
synthetic bovine papillomavirus type 1 (BPV1) late genes were constructed with codon composition modified
to resemble the typical mammalian gene. Expression of these genes from a strong promoter in Cos-1 cells was
compared with expression of wild-type BPV1 late genes from the same promoter. Both unmodified and
modified PV late genes were transcribed in Cos-1 cells, but only the codon-modified genes were translated. In
vitro translation of wild-type but not synthetic BPV1 L1 mRNA was markedly enhanced by addition of
aminoacyl-tRNAs. Codon composition thus limits BPV1 late gene translation in Cos-1 cells, and this limitation
can be overcome by modification of the codon composition of the genes or by provision of excess tRNA.
Replacement of codons in the green fluorescent protein (gfp) gene with those frequently used in PV late genes
did not alter gfp transcription in Cos-1 cells but almost abolished translation, supporting the hypothesis that
the observed differences in efficiency of translation of modified and unmodified PV capsid genes were related
to codon usage rather than mRNA structure. As tRNA populations vary within and between tissues in the same
eukaryotic organism, we speculate that matching of tRNA availability to codon usage may be one determinant
of the restriction of expression of PV late genes to differentiated epithelium.
Papillomaviruses (PV) infect stratified squamous epithelia,
and PV gene expression is linked to the state of differentiation
of the epithelial cells. Early genes associated with plasmid
replication and with regulation of host cell division and differ-
entiation are expressed at low levels in the replicating basal
cells of squamous epithelia, while the genes encoding immu-
nogenic capsid proteins (L1 and L2) are transcribed predom-
inantly in nonreplicating differentiated keratinocytes, and their
protein product can be detected only in the most superficial
layers of the epithelium (31). Transient translation of these
genes follows infection of eukaryotic cells with viral vectors
including vaccinia virus (10, 39) and baculovirus (18, 34), and
stable transcription and translation of PV late genes from
strong constitutive promoters can occur in yeast (14, 24). How-
ever, stable expression of authentic sequence late genes from
plasmid eukaryotic expression vectors, as seen in yeast, has not
been reported for replicating eukaryotic cells in vitro, although
expression in nonreplicating differentiated cells in raft culture
can be observed (22). Further, L1 translation is lost in vivo as
cells dedifferentiate (31, 37). Lack of PV late gene expression
in undifferentiated cells has been variously attributed to puta-
tive differentiation-specific transcriptional enhancers for late
promoters (2, 9), to alternate message splicing in differentiated
tissues (3), to message-processing sequences (16) or AU-rich
instability-promoting sequences (7, 30) in the 39 untranslated
sequence of L1 mRNA, to RNA sequences within the late
genes inhibitory to transcription (8, 25), or to transcriptional
repressor proteins (33). However, these proposed mechanisms
of regulation of PV late gene transcription or translation could
not explain the absence of L1 protein observed in some tissues
with abundant L1 mRNA (23).
The genetic code shows redundancy: several nucleotide trip-
lets can encode the same amino acid, and several correspond-
ing isoaccepting tRNAs are observed. Differences in the abun-
dance of isoaccepting tRNAs are observed between organisms,
and also between the tissues of a given organism, and are
postulated as one explanation for why the same gene is more or
less efficiently translated in different organisms (27). Virus
genomes frequently have a G1C content significantly different
from that of their host species, reflecting a different codon
usage pattern of unknown significance (32). Analysis of codon
usage in the PV genome shows that bovine papillomavirus type
1 (BPV1) late genes use 12 codons more than twice as fre-
quently than the average for mammalian genes (Table 1).
Similar observations apply to the late genes of other PV ge-
notypes. We therefore hypothesize that as tRNA availability in
a particular species is assumed to reflect codon usage in genes
of that species (13, 27), PV late mRNAs may not be efficiently
translated in undifferentiated cells in vitro or in vivo due to a
mismatch of codon usage and tRNA availability. If this hypoth-
esis were true, two alternate mechanisms could be proposed
for the resolution in differentiated cells of the codon usage-
tRNA mismatch in undifferentiated cells. tRNA availability
might change with keratinocyte differentiation, or a reduction
in the range and number of mRNAs competing for the rare
tRNAs might allow more effective translation. This latter hy-
pothesis could also explain why PV late gene expression can be
induced in cell cultures infected with recombinant virus, such
as vaccinia virus or baculovirus (10, 34), in which the virus
infection switches off host mRNA synthesis. If our hypotheses
are correct, conservative replacement of these codons in PV
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late genes less frequently used in mammalian genes should
result in a gene encoding mRNA which can be efficiently ex-
pressed in dividing cells in culture. We therefore produced
synthetic versions of BPV1 L1 and L2 genes, substituting
codons preferentially used by mammalian genes for the codons
in the original BPV1 L1 and L2 sequences which are less
commonly used in mammalian genes (creating so-called hu-
manized genes). We used these synthetic variants to examine
the efficiency of transcription and translation of modified and
unmodified BPV1 late genes expressed from strong constitu-
tive and natural promoters in cultured cells in vitro. In further
testing of the hypothesis, we examined whether replacing the
major codons of gfp (encoding green fluorescent protein) with
synonymous PV-preferred codons would reduce the level of
translation of gfp mRNA in cultured cells.
MATERIALS AND METHODS
Codon replacements in the BPV L1, L2, and gfp genes. The DNA and amino
acid sequences of the L1 and L2 genes are shown in Fig. 1. To determine whether
the presence in the L1 and L2 genes of codons less frequently used in mamma-
lian genes (Table 1) could in part explain the reduced translation of the L1 and
L2 genes in some mammalian cells, we synthesized codon-modified L1 and L2
genes by using synonymous substitutions as shown. To construct the synthetic
sequences, we synthesized 11 pairs of oligonucleotides for L1 and 10 pairs of
oligonucleotides for L2. Each pair of oligonucleotides has restriction sites incor-
porated to facilitate subsequent cloning (Fig. 1). The degenerate oligonucleo-
tides were used to amplify L1 and L2 sequences by PCR using a plasmid with the
BPV1 genome as the template. The amplified fragments were cut with appro-
priate enzymes and sequentially ligated to the pUC18 vector, producing
pUCHBL1 and pUCHBL2. The synthetic L1 and L2 sequences were sequenced
and found to be error free; they were then subcloned into the mammalian
expression vector pCDNA3 containing simian virus 40 (SV40) ori (Invitrogen),
giving expression plasmids pCDNA/HBL1 and pCDNA/HBL2. To compare ex-
pression of L1 and L2 with that of the original sequences, the wild-type (wt) L1
and L2 genes were cloned into the pCDNA3 vector, resulting in pCDNA/
BPVL1wt and pCDNA/BPVL2wt. To construct Pgfp, a modified gfp gene with
PV-preferred codons, six pairs of oligonucleotides were synthesized. Each pair of
oligonucleotides has restriction sites incorporated and was used to amplify gfp by
using a humanized gfp gene (GIBCO) as the template. The PCR fragments were
ligated into the pUC18 vector to produce pUCPGFP. The Pgfp gene was se-
quenced and cloned into the BamHI site of the same mammalian expression
vector, pCDNA3, under the cytomegalovirus (CMV) promoter.
To construct plasmids with the L2 gene of BPV1 in the context of the BPV1
sequence and with only BPV1 promoters, the BPV genome was cleaved at
nucleotides (nt) 4450 and 6958 with BamHI/HindIII and cloned into pUC18. In
the resultant plasmid, the original L1 (nt 4186 to 5595) and L2 (nt 5068 to 7095)
open reading frames (ORFs) were removed. The synthetic humanized L2 gene,
together with an SV40 poly(A) sequence to allow mRNA processing and the
SV40 ori sequence to allow plasmid replication in eukaryotic cells, was cleaved
from pCDNAHBL2 with HindIII/SmaI and inserted into the BamHI-cleaved
and Klenow-blunted BPV genome lacking L1 and L2 ORF sequences. This
plasmid was designated pCICR2. A similar plasmid was constructed with wt
rather than synthetic humanized L2 and designated pCICR1.
Immunofluorescence and Western blot staining. For immunoblotting assays,
Cos-1 cells in six-well plates were transfected with 2 mg of L1 or L2 expression
plasmid by using Lipofectamine (Gibco); 35 h after transfection, cells were
washed with phosphate-buffered 0.15 M NaCl, pH 7.4 (PBS), and lysed in sodium
dodecyl sulfate (SDS) loading buffer. The cellular proteins were separated by
SDS-polyacrylamide gel electrophoresis (PAGE) on a 10% gel blotted onto a
nitrocellulose membrane. The L1 and L2 proteins were identified by enhanced
chemiluminescence (Amersham, Little Chalfont, England), using BPV1 L1-spe-
cific (DAKO) or L2-specific (19) antiserum. For immunofluorescent staining,
Cos-1 cells were grown on eight-chamber slides, transfected with plasmids, and
fixed and permeabilized with 85% ethanol 36 h after transfection. The slides
were blocked with 5% milk–PBS and probed with L1- or L2-specific antiserum,
followed by fluorescein isothiocyanate (FITC)-conjugated anti-rabbit immuno-
globulin G (IgG) (Sigma). For gfp or Pgfp plasmid-transfected cells, the cells
were fixed with 4% buffered formaldehyde and viewed by epifluorescence mi-
croscopy. Data presented are representative of at least three experiments for
each transfection.
In vitro translation assay. One microgram of each plasmid was incubated with
20 mCi of [35S]methionine (Amersham) and 40 ml of T7-DNA polymerase cou-
pled rabbit reticulocyte or wheat germ lysates (Promega). Translation was per-
formed at 30°C and stopped by adding SDS loading buffer. The L1 proteins were
separated by SDS-PAGE on a 10% gel and examined by autoradiography.
Northern blotting. Cytoplasmic or total RNA was extracted from Cos-1 cells,
transfected 24 h previously with various plasmids, using a Qiagen RNeasy mini
TABLE 1. Frequency of codon usage for individual organismsa
Amino
acid Codon
Frequency (1023) of codon usage
Human Cow Yeast Wheat BPV L1and L2
Arg CGA 5.4 5.5 2.3 2.3 7.2
CGC 11.3 12.2 2.0 7.5 4.1
CGG 10.4 11.2 1.1 4.6 5.1
CGU 4.7 3.7 7.5 1.1 10.4
AGA 9.9 9.9 24.0 4.1 14.4
AGG 11.1 11.4 7.5 7.1 9.3
Leu CUA 6.2 4.9 11.8 12.1 18.6
CUC 19.9 21.2 4.1 18.6 6.2
CUG 42.5 46.6 8.3 15.5 15.5
CUU 10.7 10.6 9.6 6.5 20.7
UUA 5.3 4.0 24.5 1.8 14.5
UUG 11.0 9.6 32.1 15.3 15.5
Ser UCA 9.3 7.6 15.6 14.6 16.6
UCC 17.7 17.6 14.4 10.1 11.4
UCG 4.2 4.5 6.5 9.6 6.2
UCU 13.2 11.2 24.6 14.8 15.5
AGC 18.7 18.7 7.1 12.8 12.4
AGU 9.4 8.6 11.7 12.9 21.7
Thr ACA 14.4 11.4 15.6 4.6 37.3
ACC 23.0 21.1 13.9 15.9 19.7
ACG 6.7 7.8 6.7 4.5 4.1
ACU 12.7 9.6 22.0 11.8 28.0
Pro CCA 14.6 12.0 21.4 71.2 22.8
CCC 20.0 19.2 5.9 11.1 15.5
CCG 6.5 7.9 4.1 19.4 0.0
CCU 15.5 14.6 12.8 10.3 33.1
Ala GCA 14.0 13.1 15.3 11.2 33.1
GCC 29.1 35.8 15.5 19.5 17.6
GCG 7.2 9.3 5.1 13.8 4.1
GCU 19.6 19.1 28.3 9.6 13.5
Gly GGA 17.1 16.2 8.9 25.9 22.8
GGC 25.4 28.1 8.9 28.0 12.4
GGG 17.3 19.2 5.1 28.5 22.8
GGU 11.2 11.8 34.9 9.6 18.6
Val GUA 5.9 5.1 10.0 4.4 15.5
GUC 16.3 18.4 14.9 14.8 6.2
GUG 30.9 32.9 9.5 12.9 23.8
GUU 10.4 9.9 26.6 11.6 16.6
Lys AAA 22.2 21.6 37.7 4.5 37.2
AAG 34.9 37.1 35.2 17.4 13.5
Asn AAC 22.6 22.4 25.8 14.2 10.3
AAU 16.6 12.5 31.4 6.7 24.8
Gln CAA 11.1 9.7 29.8 171.8 22.8
CAG 33.6 34.4 10.4 79.4 17.6
His CAC 14.2 14.0 8.2 8.2 6.2
CAU 9.3 7.5 12.3 7.1 13.4
Glu GAA 26.8 24.4 48.9 7.8 36.2
GAG 41.4 45.4 16.9 19.7 21.7
Asp GAC 29.0 31.5 22.3 13.0 18.6
GAU 21.7 19.2 37.0 4.0 33.1
Tyr UAC 18.8 20.3 16.5 24.5 17.6
UAU 12.5 10.5 16.5 12.5 18.6
Cys UGC 14.5 13.9 3.7 14.8 5.2
UGU 9.9 9.4 7.6 4.9 5.2
Phe UUC 22.6 25.5 20.0 14.1 7.2
UUU 15.8 17.0 23.2 15.0 23.8
Ile AUA 5.8 5.2 12.8 5.4 22.7
AUC 24.3 25.8 18.4 19.7 8.2
AUU 14.9 13.1 31.1 10.7 20.7
a The codon usage data for human, cow, yeast, and wheat proteins are derived
from published results (20). The BPV1 data are from the sequences in the
GenBank database. Usage of triplets in boldface is more than twice as frequently
observed in PV L1 and L2 genes as mammalian consensus codons.
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FIG. 1. Nucleotide sequences of BPV1 L1 (A), L2 ORF (B) and gfp (C) and deduced amino acid sequences. Amino acids (in single-letter code) are presented below
the second nucleotide of each codon. Mutations introduced into the genes are indicated above the corresponding nucleotides of the original sequence. The sites and
enzymes used for cloning are indicated by horizontal lines. This replacement of nucleotides resulted in a polynucleotide sequence encoding BPV1 L1, L2, and GFP
polypeptides with amino acid sequences identical to the original, but having preferred (for L1 and L2 genes) or PV (for the gfp gene) codons substituted for the
synonymous codons of the wt nucleotide sequences.
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kit as instructed by the supplier. Briefly, for cytoplasmic RNA purification, buffer
RLN (50 mM Tris [pH 8.0], 140 mM NaCl, 1.5 mM MgCl2, and 0.5% Nonidet
P-40) was directly added to monolayer cells, and cells were lysed at 4°C for 5 min.
After the nuclei were removed by centrifugation, cytoplasmic RNAs were puri-
fied by column. For total RNA extraction, the monolayer cells were lysed in
buffer RLT supplied with the kit, and RNA was purified on a spin column.
Purified RNA (10 mg per lane) was separated on a 1.5% agarose gel in the
presence of formaldehyde. The RNAs were then blotted onto nylon membrane
and probed with (i) 1:1 mixed 59-end-labeled L1 wt and HBL1 fragments, (ii) 1:1
mixed 59-end-labeled L2 wt and HBL2 fragments, (iii) 1:1 mixed 59-end-labeled
gfp and Pgfp fragments, or (iv) randomly labeled glyceraldehyde-3-phosphate
dehydrogenase GAPDH fragment. The blots were washed extensively at 65°C
and exposed to X-ray films for 3 days.
Production of aminoacyl-tRNA. tRNA (2.5 3 1024 M; Boehringer) was added
to a 20-ml reaction mixture containing 10 mM Tris-acetate (pH 7.8), 44 mM KCl,
12 mM MgCl2, 9 mM b-mercaptoethanol, 38 mM ATP, 0.25 mM GTP, and 7 ml
of rabbit reticulocyte extract. The reaction was carried out at 25°C for 20 min,
and 30 ml of H2O was added to the reaction to dilute the tRNAs to 1024 M. The
aminoacyl-tRNAs were then aliquoted and stored at 270°C.
RESULTS
Expression of synthetic L1 and L2 protein in cultured cells.
To test the hypothesis that the codon composition of the genes
encoding the L1 and L2 capsid proteins of PV contributes to
their restricted expression in undifferentiated epithelial cells,
we produced synthetic BPV1 L1 and L2 genes, substituting
codons preferentially used in mammalian genes for the codons
frequently present in the wt BPV1 L1 and L2 sequences (Fig.
1). Codons where the ratio of usage in BPV1 late genes to
mammalian genes was .2, shown in boldface in Table 1, were
replaced; additionally, most codons where the ratio was .1.5
were replaced. For the L1 gene, a total of 202 base substitu-
tions were made in 196 codons, without changing the encoded
amino acid sequence (Fig. 1A). This synthetic humanized BPV
L1 gene was designated HBL1. In a similarly modified BPV1
L2 gene designated HBL2, 303 bases were changed to replace
290 less frequently used codons with the corresponding pref-
erentially used codons. Using the synthetic HBL1 and HBL2
genes, we constructed two eukaryotic expression plasmids
based on pCDNA3, designated pCDNA/HBL1 and pCDNA/
HBL2, respectively. Similar expression plasmids, constructed
with the wt BPV1 L1 and BPV1 L2 genes, were designated
pCDNA/BPVL1wt and pCDNA/BPVL2wt, respectively. In
each of these plasmids, the SV40 ori allowed replication in
Cos-1 cells, and the L1 or L2 gene was driven by a strong
constitutive CMV promoter.
To compare the expression of the synthetic humanized and
wt BPV1 L1 and BPV1 L2 genes, we separately transfected
Cos-1 cells with each of the L1 and L2 plasmids described
above. Transfected cells were analyzed for expression of L1 or
L2 protein by immunofluorescence 36 h after transfection (Fig.
2). Cells transfected with the pCDNA3 expression plasmid
containing the synthetic humanized L1 or L2 gene produced
large amounts of the corresponding protein. About 80% of
cells showed significant L1 or L2 staining, within the cell nu-
cleus as expected from the nuclear localization of these pro-
teins (38). Cells transfected with expression plasmids with the
wt L1 or L2 sequences produced no detectable L1 or L2 pro-
tein (Fig. 2). To compare more accurately the expression of the
different L1 and L2 constructs, L1 and L2 protein expression
was assessed by immunoblot analysis of Cos-1 cells transfected
with the wt or synthetic humanized BPV1 L1 or L2 pCDNA3
expression construct. Immunoreactive L1 and L2 proteins were
FIG. 1—Continued.
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FIG. 2. Expression of L1 and L2 proteins and GFP and of the corresponding mRNAs from wt or codon-modified genes. Cos-1 cells were transfected with wt or
modified L1 and L2 expression plasmids pCDNA/BPVL1wt plus pCDNA/HBL1 (row 1), pCDNA/BPVL2wt plus pCDNA/HBL2 (row 2), and pWt gfp plus P gfp (row
3). Cells were fixed after 36 h and incubated with rabbit anti-BPV1 L1 (row 1) or L2 (row 2) antiserum, followed by FITC-conjugated goat anti-rabbit IgG antibody,
and protein was visualized by immunofluorescence. L1 and L2 proteins were visible in the nuclei of cells transfected with HBL1 (row 1, panel 2) and HBL2 (row 2,
panel 2) plasmids. The cells transfected with wt L1 (row 1, panel 1) or L2 (row 2, panel 1) sequences failed to produce detectable protein. Cells transfected with
humanized gfp (row 3, panel 2) produced GFP, whereas cells transfected with the Pgfp produced little GFP (row 3, panel 3). Immunoblotting of cell lysates of
HBL1-transfected cells, and of cell transfected with purified BPV1 but not wt BPV1 L1 (row 1 panel 3), was positive for L1 protein. L2 protein appeared as a 78-kDa
band in cells transfected with HBL2 and BPV1 but not in cells transfected with wt L2 (row 2, panel 3). mRNA extracted from the cytoplasm (Cyto) or whole-cell
preparation (total) of cells transfected with control pCDNA3 (V), with pCDNA with wt or humanized (HB) L1 or L2 gene inserts, or with wt gfp or Pgfp was probed
with 32P-labelled probes made with wt L1 (row 1, panel 4) or L2 (row 2, panel 4) or gfp (row 3, panel 4) sequences. The total amount of mRNA in these samples was
examined by hybridization of the mRNA sample with a GAPDH probe (panel 4, lower).
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expressed from the synthetic humanized L1 and L2 sequences,
but no L1 or L2 protein was expressed from the wt L1 and L2
sequences (Fig. 2).
To establish whether the alterations to the primary sequence
of the L1 and L2 mRNAs which resulted from the codon
alterations also affected steady-state expression of the corre-
sponding message, total and cytoplasmic mRNAs were pre-
pared from Cos-1 cells transfected with the various capsid
protein gene constructs. Using GAPDH as an internal stan-
dard, we established by Northern blotting that two to three
times more modified than wt L1 mRNA and similar levels of wt
and modified L2 mRNAs were present in the cytoplasm of
transfected cells (Fig. 2, right panel). The total amount of L1
or L2 protein expressed in Cos-1 cell cultures per arbitrary unit
of L1 or L2 mRNA expressed was assessed by densitometry as
at least 1,000-fold higher for the humanized gene constructs
than for the natural gene constructs, confirming that the ma-
jority of the difference in level of expressed PV late protein
between the two constructs was a consequence of increased L1
or L2 translation, rather than increased gene transcription.
PV late protein translation in vitro. As the major limitation
to expression of the wt BPV L1 and L2 genes in dividing cells
in vitro appeared to be translational, we wished to test whether
this limitation reflected a limited availability of the appropriate
tRNA species for gene translation. As transient expression of
the synthetic genes within intact cells may be regulated by
many factors, we tested our hypothesis in a cell-free system
using rabbit reticulocyte lysate (RRL) or wheat germ lysate to
examine gene translation. Similar amounts of plasmids ex-
pressing the wt or synthetic humanized BPV1 L1 gene were
added to a T7-DNA polymerase coupled RRL transcription-
translation system in the presence of [35S]methionine. After 20
min, translated proteins were separated by SDS-PAGE and
visualized by autoradiography. Efficient translation of the mod-
ified L1 gene was observed (Fig. 3A, lane 2), while translation
of the wt BPV1 L1 sequence resulted in a weak 55-kDa L1
band (lane 1). We reasoned that although the wt sequence was
not optimized for translation in RRL, some translation would
occur since there would be no cellular mRNA species compet-
ing for the rare codons present in the wt L1 sequence. These
data suggest that the observed difference in efficiency of trans-
lation of the wt and synthetic humanized L1 genes is a conse-
quence of limited availability of the tRNAs required for trans-
lation of the rare codons present in the wt gene. We therefore
expected that addition of excess tRNA to the in vitro transla-
tion system would enhance translation of the wt L1 gene to a
greater extent than that of the synthetic gene. To address this
question, 1025 M aminoacyl-tRNA from yeast or bovine liver
was added to the RRL translation system and L1 protein
synthesis was assessed. Introduction of exogenous tRNAs re-
sulted in a dramatic improvement in translation of the wt L1
sequence, which now gave a yield of L1 protein comparable to
that observed with the synthetic humanized L1 sequence (Fig.
3A, right lanes). Enhancement of translation of the wt L1 gene
by aminoacyl-tRNA was dose dependent, with an optimum
efficiency at 1025 M tRNA. As addition of exogenous tRNA
improved the yield of L1 protein translated from the wt L1
gene sequence, we assessed the speed of translation of wt and
humanized L1 mRNAs. Samples were collected from the
translation mixture every 2 min, starting at min 8. Translation
of L1 from the wt sequence was much slower than that from
the humanized L1 sequence (Fig. 3B), and the retardation of
translation could be completely overcome by adding exoge-
nous liver tRNA. Addition of a comparable amount of exog-
enous liver tRNA to the humanized L1 gene expression mix-
ture somewhat enhanced expression of this gene, as might be
predicted from a mass action effect on the kinetics of protein
translation. Translation of the wt gene in the absence of exog-
enous tRNA was too slow to allow exact determination of the
increased rate of translation following addition of exogenous
tRNA but was greater than 10-fold, in contrast to the 1.3-fold
increase observed with the synthetic gene upon addition of
exogenous tRNA (Fig. 3B). In separate experiments, we estab-
lished that wt L1 translation could be similarly enhanced by
yeast tRNA (Fig. 3B) and by tRNAs extracted from bovine
skin epidermis, which presumably constitutes a mixture of
tRNAs from differentiated and undifferentiated epithelial cells
(data not shown).
Translation of wt L1 is efficient in wheat germ extract. To
further test our hypothesis that tRNA availability is a deter-
minant of expression of the wt BPV1 L1 gene, we examined the
translation of L1 in a cell type in which a quite different set of
tRNAs would be available. In a wheat germ translation system,
wt L1 mRNA was translated as efficiently as humanized L1
mRNA, and addition of exogenous aminoacyl-tRNAs did not
improve the translation efficiency of either wt or humanized
sequences (Fig. 3B). This finding suggested that in wheat germ,
in contrast to RRL, there are sufficient of the tRNAs which are
limiting for translation of wt L1 sequence in RRL to allow
efficient L1 translation.
Modified late genes can be expressed from constructs with
only the natural BPV promoters. While the data presented
above indicate that translation is limiting for the production of
BPV1 capsid proteins in our test system, these experiments
FIG. 3. For in vitro translation of BPV L1 sequences, wt BPV L1 (wt) or
synthetic L1 (HB) sequences were translated in vitro, using RRL or wheat germ
extract in the presence of [35S]methionine. (A) wt L1 or HB L1 plasmid DNA
was added to the T7-DNA polymerase coupled in vitro translation system (Pro-
mega), and L1 protein was translated for 20 min at 30°C. L1 protein was detected
by PAGE and autoradiography. The BPV L1 wt gene produced a weak L1 band
at 55 kDa (lane 1). The synthetic HBL1 gene made a larger amount of L1 protein
(lane 2). The translation reaction where only vector was added produced no
visible band (lane 3). When 1025 to 1029 M (lanes 4 to 8) bovine liver aminoacyl-
tRNA was added to the translation system, the protein translation efficiency from
wt L1 sequence was improved in a tRNA dose-dependent manner. (B) Compar-
ison of the translation efficiencies of wt L1 and HB L1 sequences in the presence
and absence of tRNA. Translation was carried out in RRL (rabbit) or wheat
germ extract (wheat), and samples were collected every 2 min starting from min
8. Addition of 1025 M bovine liver or yeast tRNA is indicated at the left.
4978 ZHOU ET AL. J. VIROL.
 o
n
 N
ovem
ber 5, 2015 by University of Queensland Library
http://jvi.asm.org/
D
ow
nloaded from
 
were conducted in systems which are not truly representative
of the viral late gene transcription from the BPV genome, in
part because the genes were driven by a strong CMV pro-
moter. We therefore wished to establish whether synthetic
humanized BPV capsid protein mRNA would be translated
more efficiently than the wt mRNA if transcribed from a plas-
mid containing only the natural BPV1 promoters. This would
establish whether translation was indeed one of the limiting
factors for expression of BPV1 late genes in the context of the
BPV1 genome and in an undifferentiated cell. Cos-1 cells were
transfected with plasmid pCICR1 or pCICR2 (Fig. 4, top pan-
el), in which the wt or synthetic humanized L2 gene was in-
serted into the BPV1 genome, cloned into pUC18. L2 protein
expression was examined by immunofluorescence of trans-
fected cells and by immunoblotting. Synthetic humanized L2
was efficiently expressed, whereas the wt L2 sequence, driven
from a similar construct, produced no immunoreactive L2 pro-
tein (Fig. 4, bottom panel). As undifferentiated cells supported
the expression of the humanized L2 gene but not the wt L2
gene expressed in the context of the BPV1 genome without an
additional promoter, the results confirmed our earlier obser-
vations from experiments using the CMV promoter. The plas-
mids tested here contained the SV40 ori, designed to replicate
the DNA in Cos-1 cells. The increased copy number of the
BPV1 L2 plasmids or the transcription-enhancing activity of
the SV40 ori might explain in part the increased efficiency of
expression of L2 in this experimental system compared with
infected skin. However, the marked difference in expression
between the natural and humanized genes seen with a CMV
promoter construct was still observed with a plasmid contain-
ing only the natural promoter, suggesting that the variation in
L2 expression efficiency observed was independent of the tran-
scriptional promoter used in our system.
Substitution of PV-preferred codons prevents translation
but not transcription of a non-PV gene in undifferentiated
cells. To further confirm that codon usage can alter gene ex-
pression in mammalian cells, we made a further variant of a
synthetic gfp gene modified for optimal expression in eukary-
otic cells (40). In our variant, codons optimized for expression
in eukaryotic cells were replaced with those preferentially used
in PV late genes. Of 240 codons in the humanized gfp gene,
which expresses high levels of GFP in cultured cells, 156 were
changed to the corresponding PV late gene-preferred codons
to produce a new gfp gene designated Pgfp. Expression of Pgfp
FIG. 4. Expression of L2 protein from the native PV promoter. (Top) Schematic representation of plasmids used to determine L2 expression from the BPV cryptic
promoter(s). The original L1 and most of the L2 sequences were deleted from the BPV1 genome by BamHI and HindIII digestion, and the remaining BPV1 sequence
was cloned into pUC18. Wild-type or synthetic humanized L2 sequences were inserted into the BamHI site of the BPV1 genome. The position of the inserted SV40
ori sequence is indicated. The plasmid where modified L2 was used but without the SV40 ori sequence was also used as a control. (Middle) The plasmids were used
to transfect Cos-1 cells, and the expression of L2 protein was determined by using BPV1 L2-specific polyclonal antiserum followed by FITC-linked anti-rabbit IgG.
Expression of L2 was observed only in cells transfected with a plasmid (pCICR2) containing the SV40 ori and a synthetic humanized L2 gene. Cells transfected with
the plasmid with the wt L2 sequence (pCICR1) with SV40 or a modified L2 sequence without the SV40 ori (pCICR3) failed to produce detectable L2 protein. A mock
transfection in which the cells did not receive a plasmid was used as a control. (Bottom) Transfected cells were subjected to SDS-PAGE and immunoblotting with a
rabbit polyvalent antibody to L2, and L2 was detected only in cells transfected with pCICR2.
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in cells in vitro was compared with that of humanized gfp.
Cos-1 cells transfected with the humanized gfp produced a
bright fluorescent signal after 24 h, while cells transfected with
Pgfp produced only a faint fluorescent signal (Fig. 2). Thus,
modification of codon usage in other genes to match that of PV
late genes can reduce expression of those genes in cell lines, as
is observed for PV late genes.
DISCUSSION
In this study, we have confirmed that one determinant of the
efficiency of expression of three different genes in dividing
mammalian cells in vitro is their codon composition. This ob-
servation has commonly been made when genes from prokary-
otic organisms have been expressed in eukaryotic cells (27),
and these data are now extended to apply to two PV genes and
one eukaryotic gene modified to resemble a PV gene in codon
composition. The differential expression of genes utilizing dif-
ferent codons to express the same protein appears predomi-
nantly to reflect different efficacy of gene translation, and
tRNA availability is apparently rate limiting for translation
when genes use codons rarely used by consensus genes from
the expression host.
Alterations to mRNA secondary structure or protein bind-
ing (29) as a consequence of the changes to the primary se-
quence of the genes might contribute to the observed differ-
ences in efficiency of translation between natural and modified
genes in cultured cells. However, the marked enhancement of
translation of the natural but not the modified mRNA that was
observed after addition of tRNA in a mammalian in vitro
translation system strengthens the argument that tRNA avail-
ability is rate limiting for translation of the natural gene in
mammalian cells. A shortage of critical tRNAs could result in
slowed elongation of the nascent peptide or premature termi-
nation of translation (21). Slowed elongation appears to be the
major consequence for the PV late gene. Analysis of codon
usage in the PV genome shows that PV late genes use many
codons that mammalian cells rarely use. For example, PV
frequently uses UUA for leucine, CGU for arginine, ACA for
threonine, and AUA for isoleucine, whereas these codons are
significantly less often used in mammalian genes. In contrast,
PV late genes can be translated efficiently when stably ex-
pressed in yeast (14, 24), and the codon compositions of yeast
and PV genes are similar (Table 1). The correlation of codon
usage in yeast genes and PV late genes is puzzling and may
simply represent chance convergent evolution. An apparent
exception to the inefficient expression of PV late genes in
dividing cells is that PV L1 genes can be expressed in insect cell
lines (18) by using recombinant baculovirus or in mammalian
cell lines by using recombinant vaccinia virus (39). As infection
with these viruses down regulates cellular protein synthesis, the
efficient expression of the L1 capsid proteins under these cir-
cumstances may occur because less cellular mRNA is available
in a virus-infected cell to compete with the L1 mRNA for the
rarer tRNAs.
Codon composition could be a more general determinant of
gene expression within different stages of differentiation of the
same tissue. Although the genetic code is essentially universal,
different organisms show differences in codon composition of
their genes, while the codon compositions of genes tend to be
relatively similar for all genes within each organism and
matched to the population of isoaccepting tRNAs for that
organism (13). However, populations of tRNAs in differenti-
ating and neoplastic cells are different (15, 35, 36), and the
tRNA populations also vary in cells growing under different
growth conditions (6). Together these observations suggest
that codon composition and tRNA availability may provide a
primitive mechanism for spatial or temporal regulation of gene
expression. It is well recognized that the G1C content of many
double-stranded DNA viruses, a crude marker for viral gene
codon composition, is markedly different from the G1C con-
tent of the DNA of the cells they infect (32). Viruses may
therefore have evolved to take advantage of codon composi-
tion to regulate their own program of gene expression, perhaps
to avoid expression of lethal quantities of viral proteins in
undifferentiated cells where the virus utilizes the cellular ma-
chinery to replicate its genome. Similar alteration of efficiency
of expression of at least one gene from human immunodefi-
ciency virus type 1 upon alteration of codon usage has recently
been described (1), although the mechanism of increased ef-
ficacy of expression was related in that study to release of
translation from dependence on human immunodeficiency vi-
rus type 1 rev. The early genes of PV, with the notable excep-
tion of E4, have codon usage patterns similar to those of the
late genes, which could explain the very low levels of expres-
sion of these proteins observed in dividing cells in vivo and in
vitro (26, 28). In keeping with our hypotheses, it has recently
been shown that the translation of at least one PV early gene,
E7, can be enhanced in vitro by addition of exogenous tRNA
(5).
As our current observations may represent an apparently
novel mechanism of regulation of gene translation within a
single tissue, it is relevant to consider how this relates to pre-
viously proposed hypotheses for the restriction of expression of
PV late genes to differentiated epithelium. It has been sug-
gested that reduced late gene expression may reflect depen-
dence of expression from the late promoter on transcription
factors expressed only in differentiated epithelium or may al-
ternatively be due to suppression of late promoter transcrip-
tion by viral (33) or cellular gene products expressed in undif-
ferentiated cells. The late promoters of human papillomavirus
types 31b and 5 (11, 12) are described as differentiation de-
pendent, although the search for relevant transcription control
factors in differentiated keratinocytes by conventional foot-
printing and DNA binding studies has been unrewarding. Our
data show that capsid proteins are not translated from PV L1
and L2 mRNAs in cells transfected with CMV promoter-based
expression vectors (Fig. 2), suggesting that in addition to any
transcriptional controls that may exist, there is also a posttran-
scriptional block to capsid protein synthesis in undifferentiated
cells. Within L1 or L2 mRNA or within flanking untranslated
message are sequences resembling 59 splice donor sites which
are inhibitory to transcription of genes with which they are
associated (8, 17). Other AU-rich sequences in L1 or L2
mRNA promote mRNA degradation (30). Consistently mod-
erately decreased levels of mRNA for the wt L1, compared
with the sequence of modified L1, were observed in the present
study following expression of these genes in Cos-1 cells. This
observation confirms that transcription or stability of wt L1
may be diminished in comparison with other genes. However,
the overall contribution of reduced transcriptional efficacy to
PV L1 expression in our systems was small in comparison to
the effect of codon usage on translational efficiency, and no
similar effect on transcription was seen for L2 although the
translational difference with the modified L2 gene was equally
large. Because untranslated inhibitory sequences were not in-
cluded in our test system, we cannot determine the roles of
inhibitory sequences and codon mismatch in suppression of PV
late gene expression in vivo. However, regulatory sequences
promoting RNA degradation or inhibiting translation are pre-
sumed to act through interaction with nuclear or cytoplasmic
proteins (29), and inefficient translation of native sequence L1
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mRNA was observed in a cell-free translation system from
anucleate cells, demonstrating that codon composition of the
PV late genes must play some role in regulation of PV late
gene translation. Further, the mechanisms shown to inhibit L1
and L2 mRNA production or increase message instability in
undifferentiated cells have yet to be shown to be inactive in
differentiated epithelium, as would be required to explain by
these mechanisms the successful translation of PV late genes in
this tissue.
Further evidence supporting the hypothesis that codon com-
position may be an important determinant of PV capsid gene
expression was gathered from an analysis of the 84 PV L1
sequences currently available in GenBank. The codon compo-
sition of the L1 genes, and particularly the frequency of usage
of the rarer codons, was essentially the same across all the
published sequences (data not shown), as would be expected
given the similar G1C contents of the PV genomes. The PV
L1 gene is relatively conserved at the amino acid level, showing
60 to 80% amino acid homology between PV genotypes, as
might be expected given the constraints on capsid protein
function. There are, however, no obvious constraining influ-
ences on the codon composition of the PV late genes beyond
those of our hypothesis, as the late gene region does not code
for other genes, either in other reading frames or on the
complementary DNA strand, and has no known cis-acting reg-
ulatory functions other than those intrinsic to L1 or L2 gene
expression. If codon composition of the capsid genes were not
important for PV function, a considerable heterogeneity of
codon usage might therefore be expected, given the evolution-
ary diversity of PVs (4).
Taken together, the data presented in this report makes a
case that codon usage should be considered as a possible de-
terminant of differential expression of PV late genes between
undifferentiated and differentiated epithelial cells, in addition
to many proven regulation mechanisms, and suggests that this
observation may be generalizable to other genes. The relative
role of message instability and codon mismatch in determining
PV late gene expression in differentiated tissues will require
comparisons of transcriptional activity and translation of the
L1 and L2 genes driven from strong constitutive promoters in
differentiated and undifferentiated epithelium. Such work us-
ing either transgenic technology or keratinocyte raft cultures
should now be feasible. The hypothesis that expression of other
genes may be regulated by tRNA availability in vivo is now
testable, as methods for fingerprinting tRNA distributions in
tissues have recently been developed (15).
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